#DEA

DEA Faces Mounting Credibility Crisis as Cannabis Rescheduling Looms

The DEA's history of corruption cases and oversight failures is raising questions about its role in cannabis rescheduling decisions, even as...

WSJ Pushes Teen Access Narrative Despite Federal Data Showing Decline

The Wall Street Journal links teen cannabis access to legalization despite DEA data showing youth use has declined. Federal surveys contradi...

Pennsylvania Senate Targets Hemp THC Products in Amended Cannabis Bill

Pennsylvania Senate committee amends cannabis bill to ban most hemp THC products, aligning with federal DEA rule changes taking effect in No...

Trump's Medical-Only Cannabis Language Raises Rescheduling Questions

Trump's executive order on marijuana rescheduling specifically mentions only medical cannabis, raising questions about whether federal refor...

AG Bondi Misses Deadline on Schedule I Research Rules

Attorney General Pam Bondi has missed a federal deadline to publish new rules making it easier for researchers to study Schedule I drugs lik...